Leukocyte-rich PRP, used in some null studies, may increase pro-inflammatory cytokines (e.g., IL-1β, MMP-9), potentially exacerbating synovial inflammation in tenosynovitis [34, 58]. This evidence concerns the gene MMP9 and tenosynovitis.